Cost-Effectiveness Analysis of Expanding the Adult Pneumococcal Vaccination Recommendations to Include Adults Aged ≥50 Years in the U.S.

American Journal of Preventive Medicine · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles